Incidence of Osteoporosis in Chronic Obstructive Pulmonary Disease Patients in a Tertiary Care Hospital: A Prospective Clinical Study

Seshagiri Rao Damaraju; Raghavendra Rao Manukonda; Haritha Sangineedy

Seshagiri Rao Damaraju Associate Professor, Department of Pulmonology
Raghavendra Rao Manukonda Professor & Head,Department of Pulmonology
Haritha Sangineedy Post-graduate Student, Department of Pulmonology

Keywords: Chronic obstructive pulmonary disease, Quality of life, Steroid therapy

Abstract

Background: The purpose of the present study is to know the incidence of osteoporosis in chronic obstructive pulmonary
disease (COPD) patients in relation to its severity and early diagnosis of osteoporosis in COPD patients and its treatment can
change quality of life of the patients.
Methods: A prospective clinical study consisted of 100 COPD patients above 40 years were undertaken to study the incidence
of osteoporosis. Of which, 74 males and 26 females were included in this study. Known COPD patients were assessed by
GOLD criteria of severity.
Results: The study group consisted of 100 patients, of which 74 are males and 26 are females. Incidence of osteopenia and
osteoporosis among males are 16.21% and 60.81% respectively. Incidence of osteopenia and osteoporosis among females
are 19.23% and 50.00% respectively (P > 0.05). Among men incidence of osteoporosis increases with an increase of grading.
It increased from 9.09% for Grade 2 to 81.81% to Grade 4 (P < 0.01). Among women incidence of osteoporosis increases with
increase of grading. It increased from 20.00% for Grade 2 to 70.00% to Grade 4 (P > 0.05). Incidence of osteoporosis is high
among patients on oral steroids 82.97%. Incidence among oral inhaled corticosteroid patients is 51.51% and on no steroids
is 10% (P > 0.05).
Conclusions: In the present study, incidence of severity of osteoporosis increases with increased grading of COPD with high
use of oral steroids. Early diagnosis of osteoporosis in COPD patients with early treatment can change the quality of life.

Author Biographies

Seshagiri Rao Damaraju, Associate Professor, Department of Pulmonology

Rangaraya Medical Collage, Kakinada, Andhra Pradesh, India

Raghavendra Rao Manukonda, Professor & Head,Department of Pulmonology

Rangaraya Medical Collage, Kakinada, Andhra Pradesh, India

Haritha Sangineedy, Post-graduate Student, Department of Pulmonology

Rangaraya Medical Collage, Kakinada, Andhra Pradesh, India

References

1. Graat-Verboom L, Smeenk FW, van den Borne BE, Spruit MA, Donkersvan
Rossum AB, Aarts RP, et al. Risk factors for osteoporosis in Caucasian
patients with moderate chronic obstructive pulmonary disease: A case
control study. Bone 2012;50(6):1234-9.
2. Global Strategy for the Diagnosis, Management, and Prevention of COPD,
Global Initiative for Chronic Obstructive Lung Disease (GOLD). Available
at: http://www.atsjournals.org/doi/abs/10.1164/rccm.200703-456so. [Last
accessed on 2014 Nov 23].
3. Hattiholi J, Gaude GS. Prevalence and correlates of osteoporosis in chronic
obstructive pulmonary disease patients in India. Lung India 2014;31:221-7.
4. Gupta RK, Ahmed SE, Al-Elq AH, Sadat-Ali M. Chronic obstructive
pulmonary disease and low bone mass: A case-control study. Lung India
2014;31:217-20.
5. Incalzi RA, Caradonna P, Ranieri P, Basso S, Fuso L, Pagano F, et al.
Correlates of osteoporosis in chronic obstructive pulmonary disease. Respir
Med 2000;94:1079-84.
6. McEvoy CE, Ensrud KE, Bender E, Genant HK, Yu W, Griffi th JM, et al.
Association between corticosteroid use and vertebral fractures in older men
with chronic obstructive pulmonary disease. Am J Respir Crit Care Med
1998;157:704-9.
7. Bolton CE, Ionescu AA, Shiels KM, Pettit RJ, Edwards PH, Stone
MD, et al. Associated loss of fat-free mass and bone mineral density in
chronic obstructive pulmonary disease. Am J Respir Crit Care Med
2004;170(12):1286-93.
8. Biskobing DM. Chest J 2002. Available from: http://www.journal.
publications.chestnet.org. [Last accessed on 2014 Nov 25].
9. Jørgensen NR, Schwarz P. Osteoporosis in chronic obstructive pulmonary
disease patients. Curr Opin Pulm Med 2008;14:122-7.
10. Grippi M, Elias J, Fishman J. Fishman’s Text Book of Pulmonary Diseases
and Disorders. 5th ed., Vol. 1. New York: Little, Brown; 1969-1973.
11. Mason RJ, Broaddus VC, Thomas M. Murray & Nadal Textbook of
Respiratory Medicine. 5th ed. Ch. 32. Philadelphia: Saunders Elsevier;
2007. p. 1288/278.
12. Watanabe R, Tanaka T, Aita K, Hagiya M, Homma T, Yokosuka K, et al.
Osteoporosis is highly prevalent in Japanese males with chronic obstructive
pulmonary disease and is associated with deteriorated pulmonary function.
J Bone Miner Metab 2014.
13. Graat-Verboom L, Spruit MA, van den Borne BE, Smeenk FW,
Martens EJ, Lunde R, et al. Correlates of osteoporosis in chronic obstructive
pulmonary disease: An underestimated systemic component. Respir Med
2009;103:1143-51.
14. Lehouck A, Boonen S, Decramer M, Janssens W. COPD, bone metabolism,
and osteoporosis. Chest 2011;139:648-57.
15. Ferguson GT, Calverley PM, Anderson JA, Jenkins CR, Jones PW,
Willits LR, et al. Prevalence and progression of osteoporosis in patients
with COPD: Results from the TOwards a Revolution in COPD Health
study. Chest 2009;136:1456-65.
16. Sin DD, Man JP, Man SF. The risk of osteoporosis in Caucasian men and
women with obstructive airways disease. Am J Med 2003;114:10-4.
17. Kanis JA. On Behalf of the World Health Organization Scientifi c Group.
Assessment of Osteoporosis at the Primary Health-care Level: Technical
Report. UK: World Health Organization Collaborating Centre for Metabolic
Bone Diseases, University of Sheffi eld; 2008.
18. Bhattacharyya P, Paul R, Ghosh M, Dey R, Dey R, Barooah N, et al.
Prevalence of osteoporosis and osteopenia in advanced chronic obstructive
pulmonary disease patients. Lung India 2011;28:184-6.